Based on gene and protein expression analyses, IL-10, S100A12, and CD274/PD-L1 were found to be increased in DLBCL patients and neutralization of these molecules resulted in an increase in both CD4 and CD8 T-cell proliferation. This evidence concerns the gene S100A12 and diffuse large B-cell lymphoma.